Search Results - "Janus"

Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis by Juqi Zhang, Juqi Zhang, Juqi Zhang, Wenhui Li, Wenhui Li, Wenhui Li, Mingli Gong, Yanlun Gu, Yanlun Gu, Yanlun Gu, Hanxu Zhang, Hanxu Zhang, Hanxu Zhang, Bingqi Dong, Qi Guo, Qi Guo, Qi Guo, Xiaocong Pang, Xiaocong Pang, Qian Xiang, Qian Xiang, Xu He, Xu He, Yimin Cui, Yimin Cui, Yimin Cui

Connect to this object online.

Janus kinase inhibitors and adverse events of acne in dermatologic indications: a systematic review and network meta-analysis by Bai-lin Chen, Shan Huang, Xiao-wan Dong, Dou-dou Wu, Yan-ping Bai, Yuan-yuan Chen

Connect to this object online.

Indirect Spectrophotometric Determination of Famotidine and Ciprofloxacin Hydrochloride in Pharmaceuticals Using N-Bromosuccinimde and Janus Green B Dye. by Muthanna Abdullah, Elham Salih

Connect to this object online.

Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis by Farnam Barati Sedeh, Thorunn Elísabet Michaelsdóttir, Mattias Arvid Simon Henning, Gregor Borut Ernst Jemec, Kristina Sophie Ibler

Connect to this object online.

Biological Evaluations and Computer-Aided Approaches of Janus Kinases 2 and 3 Inhibitors for Cancer Treatment: A Review by Lenci K. Vázquez-Jiménez, Gildardo Rivera, Alfredo Juárez-Saldivar, Jessica L. Ortega-Balleza, Eyra Ortiz-Pérez, Elena Jaime-Sánchez, Alma Paz-González, Edgar E. Lara-Ramírez

Connect to this object online.

Janus kinase 1 inhibitor abrocitinib for isolated nail lichen planus: a case report and literature review by Juan He, Yi Yang

Connect to this object online.

Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review by Siddhartha Sood, HBSc, Ahmed Bagit, BSc, Martin Heung, Khalad Maliyar, MD, Abrahim Abduelmula, MD, Muskaan Sachdeva, MD, Jorge R. Georgakopoulos, MD, Asfandyar Mufti, MD, Vimal H. Prajapati, MD, Jensen Yeung, MD

Connect to this object online.

A case of aggressive squamous cell carcinoma with lymphovascular invasion during treatment with the Janus kinase inhibitor tofacitinib by Ahmad I. Aleisa, MD, John G. Plante, BS, Ling-Lun B. Hsia, MD

Connect to this object online.

Moderate to severe atopic dermatitis in children: focus on systemic Th2 cytokine receptor antagonists and Janus kinase inhibitors by Jeong Hee Kim, Mona Salem Samra

Connect to this object online.

Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies by S. Sajith Kumar, Madhumitha Haridoss, Krishnamurthy Venkataraman, Bhavani Shankara Bagepally

Connect to this object online.

PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors by C. Garufi, S. Mancuso, F. Ceccarelli, L. Caruso, C. Alessandri, M. Di Franco, R. Priori, V. Riccieri, R. Scrivo, S. Truglia, F. Conti, F.R. Spinelli

Connect to this object online.

Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report by Camille M. Powers, Hannah Verma, Jeremy Orloff, Austin J. Piontkowski, Amy Tiersten, Angela Lamb, Nicholas Gulati

Connect to this object online.

Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective by Sara Sadeghi, Azadeh Goodarzi

Connect to this object online.

Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome with Baricitinib, a Janus Kinase Inhibitor by Yang J, Yuan C, Zhou S, Teng Z, Li M

Connect to this object online.

Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapy by David T. Beattie, M. Teresa Pulido-Rios, Fei Shen, Melissa Ho, Eva Situ, Pam R. Tsuruda, Patrick Brassil, Melanie Kleinschek, Sharath Hegde

Connect to this object online.

The Bi-(AID-1-T) G-Quadruplex Has a Janus Effect on Primary and Recurrent Gliomas: Anti-Proliferation and Pro-Migration by Svetlana Pavlova, Lika Fab, Ekaterina Savchenko, Anastasia Ryabova, Marina Ryzhova, Alexander Revishchin, Igor Pronin, Dmitry Usachev, Alexey Kopylov, Galina Pavlova

Connect to this object online.

Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future by Roberto Bursi, Giacomo Cafaro, Carlo Perricone, Ilenia Riccucci, Santina Calvacchi, Roberto Gerli, Elena Bartoloni

Connect to this object online.

At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors by Katerina Yale, MD, Aunna Pourang, MD, Maksim V. Plikus, PhD, Natasha A. Mesinkovska, MD, PhD

Connect to this object online.

Risk of nonmelanoma skin cancer in patients taking Janus kinase inhibitors for inflammatory bowel disease: A systematic review and meta-analysis by Chuen-Huei Liu, Wen-Hsuan Hou, Pi-Chu Lin, Yi-No Kang, Wei-Ting Liu, Su-Ru Chen

Connect to this object online.

Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata by Johan Mattsson, Elisabeth Israelsson, Karin Björhall, Linda Fahlén Yrlid, Kristoffer Thörn, Anna Thorén, Emelie Andersén Toledo, Lisa Jinton, Lisa Öberg, Cecilia Wingren, Sofia Tapani, Sonya G. Jackson, Gabriel Skogberg, Anders J. Lundqvist, Ramon Hendrickx, Anders Cavallin, Torben Österlund, Neil P. Grimster, Magnus Nilsson, Annika Åstrand

Connect to this object online.